| Vay Slinkey, RN | |
|
1 Hospital Rd, Belcourt, ND 58316-0160 | |
| (701) 477-6111 | |
| (701) 477-8410 |
| Full Name | Vay Slinkey |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Community Health |
| Location | 1 Hospital Rd, Belcourt, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952586844 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC1500X | Registered Nurse - Community Health | 87715 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vay Slinkey, RN Po Box 160, Belcourt, ND 58316-0160 Ph: (701) 477-6111 | Vay Slinkey, RN 1 Hospital Rd, Belcourt, ND 58316-0160 Ph: (701) 477-6111 |
News Archive
In an effort to "raise awareness around the U.S. global response to HIV/AIDS," the AIDS.gov blog has republished a post by U.S. Global AIDS Coordinator Ambassador Eric Goosby in which he discusses the XIX International AIDS Conference, taking place in the U.S. for the first time in more than 20 years from July 22-27.
In 2011, 1,166 Danes were registered with a Salmonella infection, which corresponds to 21 cases per 100,000 citizens. This is the lowest number since the 1980s. Almost half of all these Salmonella infections were contracted abroad, in particular on travels to Egypt, Thailand and Turkey.
New research from the Yale University School of Medicine discovered changes in mouth bacteria preceded the development of pneumonia in hospital patients. After studying 37 participants over the course of a month, Dr. Samit Joshi, leader of the study, concluded changes in oral bacteria play some role in a person's risk for developing pneumonia.
Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced today that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. and AZD6244 (ARRY-886*) from AstraZeneca.
› Verified 4 days ago
Ms. Kristina F Davis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 | |
Aleta Jean Peltier, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8401 | |
Shannon L Lunday, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8410 | |
Nicole L Lenoir, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8401 | |
Angela Ann Keplin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8410 | |
Crystal V Martin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8401 | |
Margaret M Pederson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8401 |